You are here

A Double Blind, Double Dummy, Randomized, Comparative Study Of The Efficacy And Safety Of Valdecoxib 40 Mg Twice Daily, As Needed In The First Menstrual Cycle Day And Then Once A Day, And Piroxicam 40 Mg Once A Day In The Treatment Of Patients With Primary Dysmenorrhea

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Salvador, Bahia, Brazil
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Dysmenorrhea
Sex
Female
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-44 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- History of primary dysmenorrhea with moderate to severe menstrual cramping pain for
which the patient took analgesic medication for at least three of six previous
menstrual cycles before enrollment

- Subjects were to have been in good health and were to have had a complete physical
exam (including a pap smear and an endovaginal or pelvic ultrasound, unless the
subject had had these examinations performed within 6 months prior to the Screening
Visit and the results were normal) prior to inclusion

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Subjects who were pregnant, lactating, breastfeeding or not using adequate methods of
birth control

NCT00649415
Pfizer
Completed
A Double Blind, Double Dummy, Randomized, Comparative Study Of The Efficacy And Safety Of Valdecoxib 40 Mg Twice Daily, As Needed In The First Menstrual Cycle Day And Then Once A Day, And Piroxicam 40 Mg Once A Day In The Treatment Of Patients With Primary Dysmenorrhea

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now